Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease BEFREE Therefore, VEGFR-1 gene variants may be involved in CAD. 31744542 2019
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease GWASCAT Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease. 29212778 2018
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease GWASCAT Association analyses based on false discovery rate implicate new loci for coronary artery disease. 28714975 2017
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease BEFREE rs9508025 in FLT1 was significantly associated with long-term cardiovascular events, particularly in patients with prior CAD. 27736948 2016
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease BEFREE Fine mapping using tag single-nucleotide polymorphisms (SNPs) at FLT1 locus revealed that another SNP (rs74412485) showed more profound genetic effect for CAD (P=2.85 × 10(-12)). 26791355 2016
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease GWASDB Large-scale association analysis identifies new risk loci for coronary artery disease. 23202125 2013
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 GeneticVariation disease BEFREE But new possible CAD-associated variant was observed for rs9508025 (FLT1), even though its statistical significance did marginally reach at the genome-wide a significance level (combined P=6.07 × 10(-7)). 23364394 2013
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.150 AlteredExpression disease BEFREE Compared to controls, there were no associations between circulating levels of IL-8, lipocalin-2, nerve growth factor (NGF), RANTES, CD-163, GPX-3, monocyte chemotactic protein-1 (MCP-1)/CCL2, leptin, soluble vascular endothelial growth factor receptor-1 (sFLT1), fatty acid binding protein-4 (FABP-4), and plasminogen activator inhibitor-1 (PAI-1) and increases in their gene expression in EAT adjacent to CAD. 21679057 2011